Third party
Health Technology Wales has published new guidance on artificial intelligence (AI) assisted review of prostate biopsies in the detection and diagnosis of prostate cancer.
Health Technology Wales has published new guidance on artificial intelligence (AI) assisted review of prostate biopsies in the detection and diagnosis of prostate cancer.
According to the guidance, there is insufficient evidence to support the routine adoption of the technology.
Health Technology Wales's guidance recommends further research to understand the clinical and cost-effectiveness of the AI systems and their impact on real-world clinical practice.
